CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA | British Journal of Cancer
Clinical Utility of Tumor Markers
Sekbio CA 242 Tumor Marker, CA 242 Blood Test Manufacturer
Cancers | Free Full-Text | Toll-Like Receptor-4 Antagonist Enhances the Repair of Ultraviolet Radiation-Induced DNA Damage and Augments Anti-Tumor Immune Responses in Mice | HTML
Clinical Value of Serum CEA, CA 19-9, CA 242 and AFP in Diagnosis of Gastrointestinal Tract Cancers
Download PDF | Comparison of a new tumour marker CA 242 with CA 19-9, CA 50 and carcinoembryonic antigen (CEA) in digestive tract diseases
CEA as a prognostic index in colorectal cancer
CA 242 | RT Diagnostics
PDF) Tumor marker CA 242 and pancreatic cancer
Cancers | Free Full-Text | Serum Tumor Markers in Pancreatic Cancer—Recent Discoveries | HTML
Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD+ and SIRT3 | Cell Death & Differentiation
Cancers | Free Full-Text | Current Pathology Model of Pancreatic Cancer | HTML
Biomedicines | Free Full-Text | Concerted Regulation of Glycosylation Factors Sustains Tissue Identity and Function | HTML
Analize medicale - Markeri tumorali | Bioclinica
Inflammation and tumor progression: signaling pathways and targeted intervention | Signal Transduction and Targeted Therapy
CA242 as a biomarker for pancreatic cancer and other diseases - ScienceDirect
PDF) CA125 and CA242 markers' role in colorectal cancer diagnosis and management – a 30 year review
Nanomedicines Targeting Glioma Stem Cells | ACS Applied Materials & Interfaces
Frontiers | From rough to precise: PD-L1 evaluation for predicting the efficacy of PD-1/PD-L1 blockades
Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases | SpringerLink
Sekbio CA 242 Tumor Marker, CA 242 Blood Test Manufacturer
GASTRIC CANCER TUMOR MARKERS – Romanian Medical Journal, Gastric cancer tumor marker
CA 242, a new tumour marker for pancreatic cancer: a comparison with CA 19-9, CA 50 and CEA | British Journal of Cancer
TAK-242 or antibiotic treatment alters tumor development in... | Download Scientific Diagram
